Background/Objectives: Oroantral fistulas (OF) are a challenging complication in oral and maxillofacial surgery, often requiring surgical intervention to restore sinus integrity. The Bichat’s buccal fat pad (BFP) has gained attention as a viable option for OF closure. This study aimed to evaluate the efficacy, safety, and clinical outcomes of BFP advancement for OF treatment. Methods: This prospective study included 20 patients diagnosed with OF. The surgical procedure involved isolation and advancement of the BFP to close the defect. Patients were followed up at 7 days, 45 days, and 6 months postoperatively, with clinical and radiographic assessments. The primary outcome was successful fistula closure at 6 months, while secondary outcomes included complication rates, sinus opacification on CT scans, pain levels, and quality of life improvements. Results: The overall success rate was 85.7%, with complete fistula closure achieved in 18 out of 21 cases (including one bilateral case). Minor complications occurred in 14.3% of cases. CT scans at 6 months showed complete resolution of sinus opacification in 81% of cases. Patients reported significant improvements in pain scores and quality of life. Conclusions: BFP advancement is an effective, safe, and minimally invasive technique for OF closure, offering high success rates and favorable clinical and radiographic outcomes. These findings support the use of BFP as a reliable option for managing OF in oral and maxillofacial surgery.
Aim: The aim of the study is to present a case of a dermoid cyst in the oral floor of an 80‐year‐old female patient and discuss its clinical presentation, diagnostic approach, and treatment. Methods: A retrospective case study was conducted at the Department of Maxillofacial Surgery, Aulss 2 Marca Trevigiana. The patient, with a medical history of hypertension, presented with a swelling in the oral floor. A clinical examination was followed by a facial CT scan with and without contrast medium to evaluate the cystic lesion. The patient underwent surgical excision under general anesthesia, with subsequent histopathological analysis. Results: The CT scan revealed a round, homogeneous, hyperdense formation with no enhancement after contrast administration. Surgical excision was performed using an intraoral approach, and histopathology confirmed the diagnosis of a dermoid cyst with an epithelial lining of predominantly squamous type. The patient experienced no complications, and follow‐up at 9 days and 2 months showed complete recovery. Conclusion: A dermoid cyst of the oral cavity, though rare in adults, should be considered in the differential diagnosis of oral floor swellings. Early diagnosis through clinical examination and imaging, followed by surgical excision, provides an effective and curative treatment.
Objective: This study aims to investigate the efficacy of marginal resection using a piezoelectric device in patients with Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ). Methods: A retrospective study was conducted on subjects treated at the Dental Clinic University Hospital of Padua (Italy) from January 2017 to April 2024. Patients diagnosed with BRONJ (stages 1 and 2) who underwent marginal resection of the maxillae using a piezoelectric instrument were included. Exclusion criteria included patients who had received radiotherapy to the head and neck, those with Medication-Related Osteonecrosis of the Jaw (MRONJ), and those with primary tumors of the maxillary bones. Marginal resection was considered an effective treatment when complete epithelialization of the surgical site was achieved, with no signs or symptoms of disease, and the condition remained stable one-year post-operation. Results: 21 patients (17 females and 4 males) were selected. A single resection was performed for each patient, resulting in a total of 21 surgeries: 14 in the mandible and 7 in the maxilla. At one-year post-surgery, 20 patients showed no signs or symptoms of the disease. 1 patient experienced two recurrences, both of which were subsequently treated. Conclusions: The study demonstrates that marginal resection using a piezoelectric device is an effective procedure for the treatment of BRONJ, although it remains a relatively invasive and destructive therapeutic approach.
Background: In 2020, the definition of Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ) was revised. The current definition is Medication-Related Osteonecrosis of the Jaws (MRONJ), to underline the fact that not only bisphosphonates are implicated in the onset of the disease. This study aims to investigate the efficacy of marginal resection using a piezoelectric device in patients with BRONJ. Methods: A retrospective study was conducted on subjects treated at the Dental Clinic University Hospital of Padua (Italy) from January 2017 to April 2024. Only patients diagnosed with BRONJ stages 1 and 2, who underwent marginal resection of the maxillae using a piezoelectric instrument were included. Patients who had received radiotherapy to the head and neck region, those with MRONJ, and those with primary tumors of the maxillary bones were excluded. Marginal resection was considered an effective treatment when complete epithelialization of the surgical site was achieved, with no signs or symptoms of disease, and the condition remained stable one-year post-operation. Results: In total, 21 patients (17 females and 4 males) were selected. A single resection was performed for each patient, resulting in a total of 21 surgeries: 14 in the mandible and 7 in the maxilla. At one-year post-surgery, 20 patients showed no signs or symptoms of the disease. One patient experienced two recurrences, both of which were subsequently treated. Conclusions: marginal resection using a piezoelectric device is an effective procedure for the treatment of BRONJ, although it remains a relatively invasive and destructive therapeutic approach.
Background/Objectives: Chlorhexidine digluconate (CHX) is widely regarded as the gold standard for oral mucosa antiseptic treatments but has been associated with delayed healing, scar formation, microbiome alterations, and fibroblast toxicity. Tocopherol, with its ability to accelerate tissue healing and minimal side effects, has emerged as a potential alternative. This randomized clinical trial aimed to compare the efficacy of topical tocopherol acetate and 0.2% chlorhexidine in managing postoperative pain and wound healing following oral cavity biopsies. Methods: Seventy-seven patients undergoing oral biopsies were divided into two groups: the test group (tocopherol acetate) and the control group (0.2% chlorhexidine). Pain was assessed using VAS (Visual Analogue Scale) scores on days 1 and 6 postoperatively, and wound healing was evaluated through measurements of the biopsy site’s height and width from standardized photographs analyzed with ImageJ. Painkiller use was also documented. The study followed CONSORT (Consolidated Standards of Reporting Trials) guidelines, with ethical approval from the Padua Ethics Committee and registration on ISRCTN. Results: No significant differences were found between the groups in VAS scores, wound dimensions, or painkiller use (p > 0.05). However, significant pain reduction within each group was observed (p < 0.0001). Conclusions: Tocopherol acetate showed comparable efficacy to chlorhexidine, suggesting it could be a viable alternative for postoperative care in oral surgery.
Background: Oral lichen planus (OLP) is a T-cell-mediated chronic inflammatory condition affecting the oral mucosa; it can present with symptoms such as a burning sensation and pain, which may significantly impair patients' quality of life. Zinc-L-carnosine (ZnC) is a chelated compound known for its anti-inflammatory properties and potential to promote mucosal repair. This study aims to evaluate the therapeutic efficacy of Hepilor, a zinc-L-carnosine-based mouthwash, in alleviating pain in patients with OLP. Materials and Methods: The study involved 19 patients with a clinical and histological diagnosis of symptomatic OLP. A randomized, double-blind, crossover clinical trial was conducted. Patients were randomly assigned to two groups that sequentially received either Hepilor mouthwash or placebo mouthwash for four weeks, separated by a four-week washout period. Patients' discomfort was assessed using the Visual Analogue Scale (VAS) for pain and the Oral Lichen Planus Symptom Severity Measure (LPOSSM) questionnaire at the beginning and end of each treatment period. Results: VAS scores decreased in the Hepilor-treated group, but not significantly. LPOSSM scores also did not show significant differences between the treatment groups. Conclusions: Although the results did not reach statistical significance, the study showed a trend toward symptom reduction in patients treated with zinc-L-carnosine. Further studies with larger sample sizes and standardized evaluation methods are needed to establish a stronger relationship between the use of zinc-L-carnosine and its efficacy in treating OLP.